For instance, in renal cell carcinoma, STING inhibits ERS-mediated pyroptosis to promote immune evasion, while targeted degradation of STING restores PERK/CHOP-dependent pyroptosis and enhances anti-tumor immunity [65]. Here, STING1 is linked to neoplasm.